Highvista Strategies LLC / BBIO
Highvista Strategies LLC’s Bridgebio Pharma Inc Position
Does Highvista Strategies LLC own Bridgebio Pharma Inc (BBIO)? Yes — 49.6K shares worth $4M (+1.02% of its 13F portfolio) as of Q1 2026, down from 80.2K shares the prior filed quarter.
Position Value
$4M
Q1 2026
Shares
49.6K
% of Portfolio
+1.02%
Quarters Held
16
currently held
Position History BBIO
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 49.6K | $4M | +1.02% |
| Q4 2025 | 80.2K | $6M | +1.58% |
| Q3 2025 | 82.0K | $4M | +1.04% |
| Q2 2025 | 67.5K | $3M | +1.07% |
| Q1 2025 | 46.5K | $2M | +0.62% |
| Q4 2024 | 46.5K | $1M | +0.47% |
| Q3 2024 | 69.1K | $2M | +0.61% |
| Q2 2024 | 44.6K | $1M | +0.41% |
| Q1 2024 | 56.6K | $2M | +0.62% |
| Q4 2023 | 44.6K | $2M | +0.65% |
| Q3 2023 | 44.6K | $1M | +0.54% |
| Q2 2022 | 105.9K | $962,000 | +0.58% |
| Q1 2022 | 85.3K | $866,000 | +0.55% |
| Q4 2021 | 33.9K | $565,000 | +0.45% |
| Q3 2021 | 24.7K | $1M | +0.76% |
| Q2 2021 | 13.1K | $796,000 | +0.56% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Highvista Strategies LLC’s full portfolio or all institutional holders of BBIO.